Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

HOTH

Hoth Therapeutics (HOTH)

Hoth Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HOTH
DateTimeSourceHeadlineSymbolCompany
09/17/20247:57AMPR Newswire (US)Hoth Therapeutics Announces Promising Preclinical Results for Alzheimer's Drug HT-ALZNASDAQ:HOTHHoth Therapeutics Inc
09/05/202410:32AMPR Newswire (US)Hoth Therapeutics Announces Expansion of Clinical Sites for HT-001 Phase 2a TrialNASDAQ:HOTHHoth Therapeutics Inc
09/05/20248:03AMPR Newswire (US)Hoth Therapeutics Announces Positive Data from First-of-its-Kind Human Patient Treatment of EGFRI-Associated Skin Toxicities with HT-001NASDAQ:HOTHHoth Therapeutics Inc
08/21/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HOTHHoth Therapeutics Inc
08/21/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HOTHHoth Therapeutics Inc
08/21/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HOTHHoth Therapeutics Inc
08/21/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HOTHHoth Therapeutics Inc
08/16/20244:15PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:HOTHHoth Therapeutics Inc
08/15/20248:04AMPR Newswire (US)Hoth Therapeutics and Aronnax Inc. Enter Master Services Agreement For HT-KIT Cancer TherapeuticNASDAQ:HOTHHoth Therapeutics Inc
08/09/20244:05PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HOTHHoth Therapeutics Inc
08/07/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HOTHHoth Therapeutics Inc
07/24/202410:30AMAllPennyStocks.comMicro Cap Already Off To The Races At The BellNASDAQ:HOTHHoth Therapeutics Inc
07/24/20246:30AMPR Newswire (US)Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's TreatmentNASDAQ:HOTHHoth Therapeutics Inc
07/16/20248:31AMPR Newswire (US)Hoth Therapeutics Expands Clinical Trial for Cancer PatientsNASDAQ:HOTHHoth Therapeutics Inc
06/18/20246:15AMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:HOTHHoth Therapeutics Inc
06/18/20246:10AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:HOTHHoth Therapeutics Inc
06/18/20246:07AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:HOTHHoth Therapeutics Inc
06/17/20244:41PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HOTHHoth Therapeutics Inc
06/10/20248:11AMPR Newswire (US)Hoth Therapeutics Announces Joint Development Agreement with Wise Systems International SRL to Utilize Artificial Intelligence for Drug DiscoveryNASDAQ:HOTHHoth Therapeutics Inc
05/14/20244:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HOTHHoth Therapeutics Inc
05/01/20248:00AMPR Newswire (US)Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024NASDAQ:HOTHHoth Therapeutics Inc
03/27/20242:00PMPR Newswire (US)Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross ProceedsNASDAQ:HOTHHoth Therapeutics Inc
03/27/20248:27AMPR Newswire (US)Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity TreatmentNASDAQ:HOTHHoth Therapeutics Inc
03/19/20248:21AMPR Newswire (US)Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZNASDAQ:HOTHHoth Therapeutics Inc
02/29/20248:38AMPR Newswire (US)Hoth Therapeutics Retains Venable LLP to Expand Its Patent PortfolioNASDAQ:HOTHHoth Therapeutics Inc
02/26/20248:11AMPR Newswire (US)Hoth Therapeutics Engages Altasciences to Perform Key Study for HT-KIT Cancer Fighting TherapeuticNASDAQ:HOTHHoth Therapeutics Inc
02/13/202411:45AMPR Newswire (US)Hoth Therapeutics to Attend BIO CEO and Investor Conference, February 26-27, 2024NASDAQ:HOTHHoth Therapeutics Inc
01/18/20248:20AMPR Newswire (US)Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill PatientsNASDAQ:HOTHHoth Therapeutics Inc
01/09/20243:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HOTHHoth Therapeutics Inc
01/08/20245:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HOTHHoth Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:HOTH